Any analysis of antitrust damages is only as good as the explanatory power of the underlying data. Meaningful data is required to demonstrate and prove damages, and also to prove the causality of a cartel for price effects. CDC has developed solutions to deliver court-proof evidence. They allow the collection, harmonisation and analysis of data from a multitude of companies through specifically designed databases and IT tools.
Database and Information Technology.
The identification of the right data requires experience and a solid background in the both economic and legal complexities of antitrust claims. We have the experience and in-depth knowledge to collect and analyse the relevant kind of data in each case. On the basis of this economic, IT and process know-how, CDC has developed a highly unique data collection and analysis process (tradebaCCC).
Importance of market-wide data.
CDC regularly collects relevant data from a multitude of companies damaged by the same cartel. The aggregate dataset creates a comprehensive picture of the respective market which is unparalleled in its breadth, depth, detail and reliability. CDC is in the position to convincingly demonstrate price developments and cartel effects in the market under investigation, and if needed across different market levels and various countries.
Overcoming the information asymmetry.
CDC´s approach of pooling data from numerous damaged companies overcomes the information asymmetry between cartel members and cartel victims. The lack of information on the damage caused by secret cartels is one of the most challenging obstacles to antitrust claims enforcement. In contrast, our comprehensive database allows for a sound economic analysis of the damages of each individual company. Single cartel victims usually do not have such a broad set of relevant data at their disposal.
The data are collected via an automated data import procedure. During the entire process we ensure the confidentiality of all data received. No damaged company has access to data and information that CDC has received from other companies.